SCHEMBL26428565

SCHEMBL26428565

O=Cc1ccc(F)c(C2CNC2)c1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 9/20 0.43
CHRNA4 P43681 9/20 0.43
CHRNB4 P30926 6/20 0.43
CHRNA3 P32297 6/20 0.43
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CHRNA7 P36544 3/20 0.36
CYP2A6 P11509 2/20 0.36
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PTGS2 P35354 1/20 0.33
RAB9A P51151 1/20 0.33
KIF11 P52732 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29955837 0.84 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CYP2A6HSD17B10TDP1
SCHEMBL2979640 0.84 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CYP2A6HSD17B10TDP1
SCHEMBL4013957 0.72 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2CYP2A6HSD17B10TDP1
SCHEMBL3586405 0.69 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2CYP2A6HSD17B10TDP1
SCHEMBL48607 0.68 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2CYP2A6HSD17B10TDP1
SCHEMBL29389102 0.68 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2CYP2A6HSD17B10TDP1
SCHEMBL24666020 0.68 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2CYP2A6HSD17B10TDP1
SCHEMBL29820680 0.68 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2CYP2A6HSD17B10TDP1
SCHEMBL23161513 0.67 CHRNB2 (0.58) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL6856211 0.66 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2CYP2A6HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067353-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 WO disclosed